![Corinne Epperly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Corinne Epperly
Directeur/Membre du Conseil chez
IN8BIO, INC.
Fortune : 2 828 $ au 31/07/2026
Profil
Corinne D.
Epperly is currently Director at Sastra Cell Therapy, Inc. since 2022 and Independent Director at IN8bio, Inc. since 2023.
Former positions include Independent Director at AVEO Pharmaceuticals, Inc. from 2021 to 2023, Research Analyst at Goldman Sachs International in 2010, Chief Operating Officer at Vascular Biogenics Ltd. from 2017 to 2018, Senior Vice President-Strategy & Operations at Iovance Biotherapeutics, Inc. from 2019 to 2020, and Chief Operating Officer at Cargo Therapeutics, Inc. from 2021 to 2023.
Education includes undergraduate studies at the University of Virginia and graduate and doctorate degrees from The University of North Carolina at Charlotte.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
IN8BIO, INC. 0,03 % | 09/05/2026 | 2 732 ( 0,03 % ) | 2 828 $ | 31/07/2026 |
Postes actifs de Corinne Epperly
| Sociétés | Poste | Début |
|---|---|---|
| IN8BIO, INC. | Directeur/Membre du Conseil | 07/12/2023 |
Sastra cell therapy, Inc.
 Sastra cell therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops cell therapies for patients with solid tumors | Directeur/Membre du Conseil | 01/03/2022 |
Anciens postes connus de Corinne Epperly
| Sociétés | Poste | Fin |
|---|---|---|
| CARO THERPAR | Directeur des opérations | 01/12/2023 |
| AVEO PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 19/01/2023 |
| IOVANCE BIOTHERAPEUTICS, INC. | Corporate Officer/Principal | 01/01/2020 |
| NOTABLE LABS, LTD. | Directeur des opérations | 01/01/2018 |
Goldman Sachs International
 Goldman Sachs International Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/10/2010 |
Formation de Corinne Epperly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
9
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Goldman Sachs International
Goldman Sachs International Investment Banks/BrokersFinance Provides brokerage services | Finance |
University of Virginia
 University of Virginia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
 AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Develops novel treatments for atherosclerosis and cancer | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
The University of North Carolina at Charlotte
 The University of North Carolina at Charlotte Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
IN8bio, Inc.
 IN8bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on delivering a novel off-the-shelf product for the treatment of cancer | Health Technology |
Cargo Therapeutics, Inc.
 Cargo Therapeutics, Inc. BiotechnologyHealth Technology Engages in generation of adoptive cell therapies for cancer treatment | Health Technology |
Sastra cell therapy, Inc.
Sastra cell therapy, Inc. Pharmaceuticals: MajorHealth Technology Develops cell therapies for patients with solid tumors | Health Technology |
